BioWorld

Dec. 6, 2004

View Archived Issues

Biomira Reports Phase IIb Data In Lung Cancer; Stock Rockets

Biomira Inc. watched its stock more than double Friday following positive Phase IIb data of its BLP25 liposome vaccine that showed a huge survival benefit for Stage IIIB non-small-cell lung cancer patients. (BioWorld Today) Read More

After Four Years, Thompson Steps Down As HHS Head

Read More

BioSante Affected By FDA Panel Vote On P&G Product

Read More

Still Fighting, Genta Acquires Phase I Antisense Drug Rights

Read More

Other News To Note

Read More

Appointments And Advancements

Read More